PharmaCyte Biotech
(NASDAQ) PMCB
PharmaCyte Biotech Financials at a Glance
Market Cap
$7.20M
Revenue (TTM)
$0.00
Net Income (TTM)
$3.28M
EPS (TTM)
$-1.04
P/E Ratio
-0.64
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$0.69
Volume
10
Open
$0.69
Price
$0.69
Volume
10
Open
$0.69
Previous Close
$0.67
Daily Range
$0.67 - $0.75
52-Week Range
$0.63 - $1.51
Dividend
$0.00
Beta (Volatility)
0.53 (Low)
Price
$0.69
Volume
10
Open
$0.69
Previous Close
$0.67
Daily Range
$0.67 - $0.75
52-Week Range
$0.63 - $1.51
PMCB News
PMCB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PharmaCyte Biotech
Industry
Biotechnology
Sector
Health CareEmployees
2
CEO
Joshua Nathaniel Silverman
Website
pharmacyte.comHeadquarters
Las Vegas, NV 89169, US
PMCB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-8%
Return on Capital
-10%
Return on Assets
-6%
Earnings Yield
-1.56%
Dividend Yield
0.00%
Payout Ratio
-4.96%
Stock Overview
Market Cap
$7.20M
Shares Outstanding
10.74M
Volume
10
Short Interest
0.00%
Avg. Volume
240.99K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$4.38M
EBITDA
$30.66M
Operating Cash Flow
$2.98M
Capital Expenditure
$4.00
Free Cash Flow
$2.98M
Cash & ST Invst.
$15.54M
Total Debt
$0.00
PharmaCyte Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.20M
N/A
Market Cap/Employee
$3.60M
N/A
Employees
2
N/A
Net Income
$746.86K
+124.5%
EBITDA
$2.12M
-120.6%
Quarterly Fundamentals
Net Cash
$20.54M
+22.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-5.87%
N/A
Return on Invested Capital
-9.94%
N/A
Free Cash Flow
$786.85K
-54.3%
Operating Cash Flow
$786.85K
-54.3%